Skip to main content
Pediatric HealthStudy Findings· 6 min read· in Lifestyle

One in Six Children on GLP-1 Drugs Develop Nutritional Deficiency, Study Finds

A new analysis of insurance claims reveals that nearly 17% of adolescents taking GLP-1 medications for weight loss or diabetes develop a diagnosed nutritional shortfall within a year.

By Julien Moreau

Pediatric Researchers 40%Clinical Dietitians 35%Public Health Officials 25%
Pediatric Researchers
Advocating for proactive nutritional monitoring as a standard part of GLP-1 treatment.
Clinical Dietitians
Focusing on maximizing the nutrient density of smaller meals.
Public Health Officials
Balancing the urgent need to treat rising childhood obesity rates against the emerging risks of new pharmaceutical interventions.

Perspectives this story doesn't cover

  • Insurance Providers
  • Adolescent Patients

Fast facts

  • Nearly 17% of adolescents on GLP-1 medications developed a nutritional deficiency within one year of starting treatment.
  • Vitamin D deficiency was the most common shortfall, affecting 12.4% of the young patients studied.
  • Despite the risks to growing bodies, only 5.8% of patients received nutritional counseling within their first 30 days on the drugs.
  • Researchers urge doctors to integrate proactive dietary planning into pediatric GLP-1 care rather than waiting for deficiencies to appear.

Why this matters

Adolescence is a critical window for bone growth and muscle development. As GLP-1 medications become a frontline treatment for childhood obesity and diabetes, understanding how a suppressed appetite limits essential vitamin intake allows parents to proactively protect their child's long-term physical development.

For parents helping their teenagers navigate weight loss or diabetes with GLP-1 medications, the daily routine now requires a much closer look at the dinner plate. According to a comprehensive new analysis of medical records, nearly one in six adolescents on these drugs develops a diagnosed nutritional deficiency within their first year of treatment. The reality of a medically suppressed appetite means that families can no longer rely on sheer volume of food to deliver essential vitamins, fundamentally changing how they must approach mealtime and grocery shopping to protect their child's health.[1][2][4]

The findings, published September 17, 2026, in the journal Childhood Obesity, turn a spotlight on the hidden cost of a suddenly shrunken appetite. When a child simply stops feeling hungry, the few bites they do take need to work much harder to supply the calcium, iron, and vitamins required for their growing bodies. This shifts the focus of pediatric weight management from simply reducing caloric intake to actively ensuring that the calories consumed carry enough essential micronutrients to sustain healthy development.[4]

To understand how these medications affect growing bodies, researchers combed through a massive pool of United States insurance claims from 2017 through 2022. They zeroed in on 2,031 children and teenagers, aged 10 to 17, who had just started a GLP-1 receptor agonist and had a clean bill of nutritional health beforehand. By tracking these patients over time, the study authors aimed to uncover whether the dramatic reduction in food intake triggered by the drugs was inadvertently starving these adolescents of the basic building blocks they need during their most critical years of physical maturation.[2][4]

The group—averaging 15 years old and 61.5% female—mostly relied on liraglutide, which accounted for 78.6% of the prescriptions, while dulaglutide and semaglutide made up the rest. Within just six months of their first injection, 10.2% of these young patients were diagnosed with a nutritional shortfall. By the end of a full year, that number reached 16.88%. These figures highlight a rapid onset of dietary gaps, suggesting that the nutritional reserves of a teenager can be depleted in a matter of months when their daily food intake drops precipitously without a targeted nutritional strategy in place.[2][4]

Liraglutide was the most commonly prescribed GLP-1 medication among the adolescents tracked in the study.

Vitamin D deficiency was the most frequent hurdle, showing up in 12.4% of the teenagers. Without enough vitamin D, growing bones struggle to absorb calcium, putting skeletal strength at risk during a vital window of development. Nutritional anemia appeared in 1.55% of the teens, and specific iron-deficiency anemia affected another 1.44%. While those percentages may sound small, they represent real adolescents left vulnerable to chronic fatigue, weakness, and brain fog during crucial school years, all because their reduced diets failed to deliver enough iron to keep their red blood cells functioning properly.[2][4]

Vitamin D deficiency was the most frequent hurdle, showing up in 12.4% of the teenagers.

The root of the problem lies in how effectively the drugs work. GLP-1 medications slow the emptying of the stomach and signal profound fullness to the brain, which is exactly why they succeed in treating obesity. But when a teenager skips breakfast because they feel full and only picks at a sandwich for lunch, they miss out on the baseline micronutrients their bodies expect. The sheer mechanics of the medication mean that casual eating habits are no longer sufficient to support pubertal development, muscle building, and the intensive biological changes that define the teenage years.[1][2]

"As appropriate pediatric use of GLP-1s becomes more widespread, we need to understand the risks during periods of rapid growth and pubertal development," said Justin Ryder, Vice Chair of Research for the Department of Surgery at Ann & Robert H. Lurie Children's Hospital of Chicago and the study's senior author. Ryder's team recognized that while the medications offer a powerful tool against metabolic disease, they also introduce a new variable into pediatric care that doctors and parents have not historically had to manage at this scale.[5]

"Nutrients such as vitamin D, iron and calcium are of particular concern during adolescence, when deficiencies may have lasting implications for skeletal health and overall development," Ryder explained in a Northwestern University release. Because teenagers are actively building the bone density that will carry them through the rest of their lives, a year spent in a severe vitamin deficit is not just a temporary inconvenience; it is a structural risk that requires immediate and sustained intervention from healthcare providers.[5]

Yet, despite these high stakes, very few families are getting a roadmap for how to feed a child who has lost their appetite. The study found that a mere 5.8% of the children sat down with a nutrition counselor within their first 30 days on the medication. Even after six months, only 23.3% had received professional dietary guidance, and they waited an average of 149 days for that first appointment. This delay leaves parents guessing in the grocery aisle during the exact months when their child's dietary habits are undergoing the most drastic transformation.[2][4]

Despite the risks of reduced food intake, fewer than a quarter of patients received dietary counseling within their first six months of treatment.

The data also revealed a counterintuitive twist: teens who saw a nutritionist had higher rates of diagnosed deficiencies (23.2%) than those who navigated the treatment alone (14.8%). Researchers note this likely reflects the reality of medical testing rather than a failure of counseling. Dietitians are the professionals most likely to order the specific blood work that catches missing vitamins, and doctors often only refer a family to a nutritionist after a routine blood test flashes a warning sign, meaning the higher rate is a product of better detection.[4]

The stakes for getting this balance right are immense, as the medical community cannot afford to abandon these therapies. The Centers for Disease Control and Prevention notes that 22% of adolescents aged 12 to 19 currently live with obesity, making effective treatments like GLP-1s a vital tool for long-term health. The goal is not to pull teenagers off the medication, but to modernize the standard of care so that nutritional safeguarding becomes as routine as checking a patient's weight or blood pressure during a follow-up visit.[6]

Experts urge healthcare providers to integrate nutritional planning into GLP-1 treatment from the very first prescription.

For families, the research offers a clear, actionable blueprint for the months ahead. Instead of waiting for a teenager to feel exhausted from iron depletion or for a blood test to reveal a severe vitamin D shortage, parents and pediatricians can build a nutrition plan from day one. By ensuring that every smaller meal is anchored by protein, dark leafy greens, and nutrient-dense whole foods, families can harness the benefits of the medication while giving a growing body the essential building blocks it cannot afford to skip.[1][2]

Viewpoints in depth

Pediatric Researchers

Advocating for proactive nutritional monitoring as a standard part of GLP-1 treatment.

Researchers emphasize that adolescence is a non-negotiable window for bone accrual and physical development. Because GLP-1 medications drastically reduce the volume of food a teenager consumes, scientists argue that waiting for symptoms of anemia or vitamin D deficiency to appear is a flawed strategy. They advocate for integrating baseline blood panels and immediate dietary counseling into the standard prescription protocol, ensuring that the benefits of weight loss do not come at the expense of long-term skeletal and muscular health.

Clinical Dietitians

Focusing on maximizing the nutrient density of smaller meals.

For dietitians, the challenge of GLP-1 medications is shifting a family's mindset from calorie restriction to nutrient maximization. When a teenager's appetite is chemically suppressed, every bite must carry its weight in essential vitamins and minerals. Dietitians stress the importance of anchoring meals with high-quality proteins, calcium-rich dairy, and iron-heavy leafy greens, warning that casual eating habits—which might suffice for a teenager with a normal appetite—will quickly lead to depletion when overall food volume drops.

Parents and Caregivers

Balancing the relief of effective treatment with the anxiety of new dietary hurdles.

Families navigating pediatric obesity or type 2 diabetes often view GLP-1 medications as a life-changing intervention. However, the profound loss of appetite introduces a new layer of daily anxiety. Parents find themselves struggling to persuade a teenager who simply isn't hungry to consume enough protein and vitamins. For caregivers, the study validates their concerns and highlights the urgent need for professional guidance, transforming the dinner table from a battleground over portion size into a strategic effort to deliver essential nutrition.

Sources

Source coverage

6 outlets

3 viewpoints surfaced

Pediatric Researchers 40%Clinical Dietitians 35%Public Health Officials 25%
  1. [1]Contemporary PediatricsPediatric Researchers

    GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds

    Read on Contemporary Pediatrics
  2. [2]The Pharmaceutical JournalClinical Dietitians

    Children taking GLP-1s can be at risk of nutritional deficiencies, study finds

    Read on The Pharmaceutical Journal
  3. [3]LabrootsClinical Dietitians

    GLP-1 Drugs Linked to Nutritional Deficiencies in Youth

    Read on Labroots
  4. [4]Childhood ObesityPediatric Researchers

    Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists

    Read on Childhood Obesity
  5. [5]Northwestern UniversityPediatric Researchers

    GLP-1s linked to nutritional deficiencies in children

    Read on Northwestern University
  6. [6]Centers for Disease Control and PreventionPublic Health Officials

    Childhood Obesity Facts

    Read on Centers for Disease Control and Prevention

Comments

Stay informed

Every angle. Every day.

Get Lifestyle stories with full source coverage and perspective breakdowns delivered to your inbox.